Literature DB >> 6302523

The positive inotropic effect of aconitine.

P Honerjäger, A Meissner.   

Abstract

1. The inotropic and electrophysiological effects of aconitine were measured in the isolated, isometrically contracting guinea-pig papillary muscle during the prearrhythmic phase of alkaloid action. 2. In muscles stimulated continually at 1 Hz, 1 mumol/l aconitine produced a positive inotropic effect that reached 38 +/- (SEM) 9% immediately before the onset of arrhythmia (n = 3). 3. If aconitine (0.5 mumol/l) was applied to non-stimulated (resting) muscles for 30 min and 1-Hz stimulation resumed thereafter, the arrhythmia occurred after 724 +/- 101 beats. Prolongation of the rest exposure to 2 h did not significantly diminish the number of prearrhythmic beats. Thus, the onset of aconitine action is critically determined by muscle activity (rather than by time), and a 30-min aconitine application to the resting muscle suffices for complete equilibration of the tissue. 4. Using the preequilibration-at-rest procedure, the positive inotropic effect of aconitine (0.25 - 4 mumol) was found (a) to be absent in the rested-state contraction, (b) to grow with both number of subsequent beats and alkaloid concentration, and (c) to reach a similar prearrhythmic maximum at all concentrations. This maximum amounted to about 1/4 of the maximum positive inotropic effect of dihydroouabain. It was not influenced by reserpine pretreatment of the guinea pig. 5. Aconitine (1 mumol/l) delayed the repolarization phase of the action potential by establishing a secondary plateau at approximately -60 mV. This effect paralleled the positive inotropic effect and, like the positive inotropic effect, was abolished by 10 mumol/l tetrodotoxin (TTX). In partially depolarized muscles ([K]0 = 24 mmol/l) aconitine (8 mumol/l) produced a TTX-sensitive increase in amplitude and rate of rise of the rested-state contraction; this indicates a voltage-dependent effect on some resting Na channels. 6. While delaying the late repolarization phase, aconitine markedly shortened the early repolarization at levels positive to -40 mV, reduced the overshoot and decreased the maximum rat of depolarization of the action potential. Slow action potentials ([K]0 = 24 mmol/l; 10 mumol/l TTX) were insensitive to aconitine. 7. We conclude that the well known property of aconitine to prolong the Na influx during the action potential leads to a positive inotropic effect, thus confirming the importance of Na influx for the regulation of myocardial contractility. The exact mechanism of an additional effect by which aconitine reduces the overshoot and shortens the plateau phase of the action potential awaits further study.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6302523     DOI: 10.1007/bf00649352

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  3 in total

Review 1.  The action of cardiotoxins on cardiac plasma membranes.

Authors:  M Lazdunski; J F Renaud
Journal:  Annu Rev Physiol       Date:  1982       Impact factor: 19.318

Review 2.  Sodium-calcium exchange in the heart.

Authors:  G A Langer
Journal:  Annu Rev Physiol       Date:  1982       Impact factor: 19.318

Review 3.  Neurotoxins that act on voltage-sensitive sodium channels in excitable membranes.

Authors:  W A Catterall
Journal:  Annu Rev Pharmacol Toxicol       Date:  1980       Impact factor: 13.820

  3 in total
  11 in total

1.  Hydroxylation Metabolisms of Crassicauline A in Rats Under Toxic Dose.

Authors:  Xue Fan; Shan-Shan Yin; Xue-Jing Li; Kui Yang; Liang Xu; Ke Lan
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-10       Impact factor: 2.441

2.  Selective inhibition of persistent sodium current by F 15845 prevents ischaemia-induced arrhythmias.

Authors:  C Pignier; J-S Rougier; B Vié; C Culié; Y Verscheure; B Vacher; H Abriel; B Le Grand
Journal:  Br J Pharmacol       Date:  2010-09       Impact factor: 8.739

Review 3.  The immuno-oncological challenge of COVID-19.

Authors:  Lisa Derosa; Cléa Melenotte; Franck Griscelli; Bertrand Gachot; Aurélien Marabelle; Guido Kroemer; Laurence Zitvogel
Journal:  Nat Cancer       Date:  2020-10-02

4.  Biological Evaluation of Polyherbal Ayurvedic Cardiotonic Preparation "Mahamrutyunjaya rasa".

Authors:  Pallavi D Rai; Sadhana J Rajput
Journal:  Evid Based Complement Alternat Med       Date:  2010-09-02       Impact factor: 2.629

5.  Sarcoplasmic reticulum Ca2+ release channel ryanodine receptor (RyR2) plays a crucial role in aconitine-induced arrhythmias.

Authors:  Min Fu; Ru-Xin Li; Li Fan; Guo-Wei He; Kent L Thornburg; Zhao Wang
Journal:  Biochem Pharmacol       Date:  2008-02-29       Impact factor: 5.858

Review 6.  Stress, depression and cardiovascular dysregulation: a review of neurobiological mechanisms and the integration of research from preclinical disease models.

Authors:  Angela J Grippo; Alan Kim Johnson
Journal:  Stress       Date:  2009-01       Impact factor: 3.493

7.  The mode of inotropic action of ciguatoxin on guinea-pig cardiac muscle.

Authors:  A Seino; M Kobayashi; K Momose; T Yasumoto; Y Ohizumi
Journal:  Br J Pharmacol       Date:  1988-11       Impact factor: 8.739

8.  L-Type Calcium Channel Inhibition Contributes to the Proarrhythmic Effects of Aconitine in Human Cardiomyocytes.

Authors:  Jianjun Wu; Xiangchong Wang; Ying Ying Chung; Cai Hong Koh; Zhenfeng Liu; Huicai Guo; Qiang Yuan; Chuan Wang; Suwen Su; Heming Wei
Journal:  PLoS One       Date:  2017-01-05       Impact factor: 3.240

9.  Sweroside Alleviated Aconitine-Induced Cardiac Toxicity in H9c2 Cardiomyoblast Cell Line.

Authors:  Li-Qun Ma; You Yu; Hui Chen; Mei Li; Awais Ihsan; Hai-Ying Tong; Xian-Ju Huang; Yue Gao
Journal:  Front Pharmacol       Date:  2018-10-25       Impact factor: 5.810

10.  Arrhythmogenesis toxicity of aconitine is related to intracellular ca(2+) signals.

Authors:  Yu-hong Zhou; Xian-mei Piao; Xue Liu; Hai-hai Liang; Lei-min Wang; Xue-hui Xiong; Lu Wang; Yan-jie Lu; Hong-li Shan
Journal:  Int J Med Sci       Date:  2013-08-01       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.